Julie Rubinstein, President at Adaptive Biotechnologies Corp (ADPT), sold 29,155 shares at $57.54 ($1.7M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $1.7M ADPT by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.54 | 4,684 | $270K | 15.9% |
| 2 | $57.54 | 4,684 | $270K | 15.9% |
| 3 | $58.64 | 9,471 | $555K | 32.7% |
| 4 | $58.64 | 9,471 | $555K | 32.7% |
| 5 | $58.99 | 845 | $50K | 2.9% |
| Total | $58.30 avg | 29,155 |
| $1.7M |
| 100% |
| Filing → |
| ADPT | SELL | 2026-10-08 | $948K | — | Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |